News
The most up to date reporting and breakthroughs in anal cancer and HPV research, and Anal Cancer Foundation’s latest activities and events.
2023 Anal Cancer Patient Summit Speaker Bios
Join us at our 2023 patient summit! Cathy Eng, M.D., FACP, FASCO Cathy Eng, MD, FACP, FASCO, Professor of Medicine, Hematology and Oncology, is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program. She joined the faculty at Vanderbilt-Ingram Cancer Center in July 2019. Her primary clinical research interests include clinical… read more
Advocating for an HPV Cancer Awareness Campaign: The Anal Cancer Foundation Visits Capitol Hill
The executive director of the Anal Cancer Foundation, Justine Almada, recently traveled to Washington, D.C. to meet with legislators on Capitol Hill. Her mission was clear: to advocate for an HPV Cancer Awareness Campaign and secure more funding for anal cancer and the other cancers caused by HPV. The Anal Cancer Foundation has been at… read more
2022 Year in Review
The Anal Cancer Foundation is starting yet another exciting year! With new partnerships forged and enlightening conversations with more experts in the anal cancer field, we feel as invigorated as ever for the new adventures 2023 will bring. If you missed it, please read about our advocacy push last month for the first national anal… read more
Thrivers Share Testimony with US Preventive Services Task Force
In January, the US Preventive Services Task Force (USPSTF) opened their draft research plan on anal cancer screening to public comment. This is the first time the Task Force has considered whether to recommend screening for anal cancer. Despite available treatments for precancer, anal cancer is not routinely screened for. Today, a correct and early… read more
2022 Virtual Patient Summit: 1 October
The 2022 Virtual Anal Cancer Patient Summit is an opportunity for anal cancer advocates, patients, and caregivers to learn, connect, and be empowered! Sessions will feature invited speakers: from oncologists to physical therapists, to thrivers who have faced anal cancer themselves. We look forward to bringing together the anal cancer community for a day dedicated… read more
Rare and Misunderstood: An IANS Annual Meeting Patient Panel
On June 5th, the third day of the 2022 International Anal Neoplasia Society (IANS) Scientific Meeting in New York, a panel of brave and outspoken thrivers shared their experiences with the assembled medical experts, in a session entitled. “Rare and Misunderstood: Ten Years Later – Narratives and Perspective on the Anal Cancer Experience.” The session… read more
2022 International Anal Neoplasia Society Scientific Meeting
On June 3-5, researchers and medical professionals from all over the globe came together at the 2022 International Anal Neoplasia Society (IANS) Scientific Meeting In New York. They gathered to discuss best practices in anal cancer prevention and treatment, presenting their research and specific clinic experiences. Anal cancer and pre-cancer data were also shared by… read more
ANCHOR Trial Q & A
The groundbreaking ANCHOR study showed that early detection and treatment of anal HSIL (anal precancer) reduces cancer progression by 57%. Today, the study and results were published in the New England Journal of Medicine. The study was conceived by Anal Cancer Foundation scientific advisory board member Dr. Joel Palefsky, and supported through advocacy efforts by the… read more
A successful start to our 2022 Expert Hour webinar series!
We recently held the inaugural webinars in our 2022 Expert Hour webinar series: Clinical Trials 101 and Immunotherapy 101. Dr. Lee Rosen of the University of California, Los Angeles, and Dr. Julius Strauss of the National Institutes of Health were the first two experts to hold informative and insightful sessions. We were thrilled at the… read more
Reminder: Register for Expert Hour Webinar—Immunotherapy 101
We hope you will join us for a webinar for anal cancer thrivers and caregivers focused on immunotherapy! Date: Thursday, April 21 Time: 9am Pacific | 12pm Eastern Dr. Julius Strauss, medical oncologist and lead researcher at the National Cancer Institute, explains how immunotherapy works, who can benefit, key terms, and existing treatment and trials…. read more
